Status:
COMPLETED
Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Varian Medical Systems
Conditions:
Brain Cancer
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer. The Halcyon 4.0 system has been engine...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- Planning to receive radiation therapy to one of the following sites:
- Head and neck/brain (n=10)
- Thorax (n=10)
- Abdomen (n=10)
- Pelvis (n=10)
- At least 18 years of age
- If the patient will be receiving IV contrast on study: Adequate renal function as defined by a serum creatinine \< 1.4, or, for patients with chronic kidney disease, a stable serum creatinine \< 2.0. Note: if no IV contrast will be administered on study, patient may enroll without creatinine level documented.
- If the patient is a woman of childbearing potential, a negative pregnancy test must be obtained. Contraceptive use is not an adequate documentation of no chance of pregnancy.
- Able to understand and willing to sign an IRB approved written informed consent document.
Exclusion
Key Trial Info
Start Date :
August 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 17 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT05427214
Start Date
August 19 2022
End Date
October 17 2024
Last Update
October 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110